With acquisition of Canadian software developer Radimetrics Inc., health care giant Bayer signaled its intentions to be a major player in the radiology business arena.
“This is a strategic acquisition as Bayer moves its Radiology & Interventional business forward to be the end-to-end provider of products, solutions and service for the radiology customer,” said Alan Main, head of Bayer HealthCare’s Medical Care division, in the company’s press release.
Toronto-based Radimetrics Inc. is the developer of eXposure, a software solution for measuring patient radiation exposure that can also manage reporting and scanner protocols. It is already integrated with many hospital and medical group PACS/RIS systems, and the acquisition by Bayer will speed its adoption in the market, Main said in the release.
Radimetrics’ employees in Toronto and Scotland will become part of Bayer’s international workforce, which totaled 55,700 people as of the end of last year.
Bayer HealthCare is based in Leverkusen, Germany, and is a subgroup of the German company Bayer AG. Total annual sales for Bayer AG last year was more than $22 billion.